Related Experiment Videos
Oxytocin in active-phase abnormalities of labor: a randomized study
1King's College Hospital, London, England.
Obstetrics and Gynecology
|February 1, 1990
Summary
Oxytocin effectively treats abnormal labor, including primary dysfunctional labor and secondary arrest of cervical dilatation, outperforming saline. This labor induction method did not increase cesarean delivery rates for fetal distress.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
- Clinical Pharmacology
Background:
- Abnormal labor, encompassing primary dysfunctional labor and secondary arrest of cervical dilatation, affects a significant proportion of deliveries.
- Effective interventions are crucial to improve labor progression and maternal/fetal outcomes.
Purpose of the Study:
- To compare the efficacy of oxytocin versus saline in managing abnormal labor.
- To evaluate the impact of oxytocin on labor progression and the rate of cesarean delivery.
Main Methods:
- An open randomized trial involving 759 women with abnormal labor.
- Patients received either oxytocin or saline, with crossover permitted for non-responders.
- End points included the rate of cervical dilatation and changes in cervical dilatation.
Main Results:
- Oxytocin demonstrated significantly superior efficacy compared to saline in treating both primary dysfunctional labor and secondary arrest of cervical dilatation.
- The administration of oxytocin did not lead to an increased requirement for cesarean delivery due to fetal distress.
Conclusions:
- Oxytocin is a highly effective agent for managing abnormal labor, offering significant benefits over saline.
- The use of oxytocin in labor induction is safe regarding fetal well-being, as evidenced by the lack of increased cesarean deliveries for fetal distress.